Clinical Trial Update: A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs [Phase 1, Phase 2]

View source ↗

Summary

Krystal Biotech's KB707 is being evaluated in a Phase 1/2 study for advanced solid tumors affecting the lungs, including non-small cell and metastatic disease. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KB707

Snippet

Sponsor: Krystal Biotech, Inc. | Conditions: Lung Cancer, Non-small Cell, Lung Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING